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treatment patterns, and marginal structural models (MSMs).
MSMs utilize all of the data, account for the treatment switch-
ing, while adjusting for selection bias and patient dropout.
RESULTS: Over 25% of 664 randomized patients switched
treatments during the study, 7% augmented their randomized
treatment, and another 28% discontinued early. Switching was
greatest among patients randomized to conventional anti-
psychotics (45% switched to atypicals, <20% of atypical patients
switched therapies). Treatments did not differ in BPRS total score
using various intent-to-treat analyses including last-observation-
carried-forward. However, MSMs and other approaches that
took into account the treatment switching demonstrated statis-
tically signiﬁcantly greater symptom reduction for patients
treated with olanzapine as compared to conventional anti-
psychotics (overall treatment difference: 4.2 points, p = 0.007).
CONCLUSIONS: Drawing inferences on treatment effects in
longitudinal naturalistic studies is challenging due in part to
patients changing or stopping medications over time. In this
study, standard methods did not address treatment effectiveness,
while MSMs provided a framework for addressing effectiveness
in the presence of switching, selection biases, and early dropout.
The MSM analysis showed olanzapine to be superior to con-
ventional anti-psychotics in reducing schizophrenic symptom
severity.
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OBJECTIVES: The study was conducted to examine following
hypotheses: Tricyclic Antidepressants (TCAs) use increases the
risk of colorectal cancer. In particular, the use of genotoxic TCAs
increases the risk as compared to non-genotoxic TCAs. The use
of Selective Serotonin Reuptake Inhibitors (SSRIs) decreases the
risk of colorectal cancer. METHODS: A population-based nested
case-control study was conducted using source population who
individually participate in the Saskatchewan Prescription Drug
Plan aged 5–82.5 years from 1981–2000 with no previous
history of cancer since 1967. A total of 6544 histologically
proven invasive colorectal cancer patients were identiﬁed from
the Saskatchewan Cancer Registry. For each case, four eligible
non-cancer controls matched on age, gender and calendar time
were randomly selected. The effects of antidepressant use were
examined by conditional logistic regression, considering dosage,
duration and timing of antidepressant use. RESULTS: A signiﬁ-
cant increased risk of colorectal cancer was observed for medium
dose and duration of TCAs use during 16–20 year period pre-
ceding diagnosis without signiﬁcant dose-response effect (Inci-
dence rate ratio (RR) for dose = 1.51, 95% conﬁdence interval
= (1.09–2.09); RR for duration = 1.60 (1.13–2.27)). No signiﬁ-
cant increased risk was observed among users of genotoxic
TCAs, while a signiﬁcantly increased risk was observed among
persons exposed to medium duration of non-genotoxic TCAs
during 16–20 years preceding diagnosis without signiﬁcant dose-
response effect (RR = 1.89 (1.14–3.14)). Signiﬁcant decreased
risk of colorectal cancer was observed among subjects heavily
exposed to SSRIs during 5-year periods preceding diagnosis (RR
for dosage = 0.62 (0.43–0.90), P-value of test for trend = 0.01;
RR for duration = 0.71 (0.50–1.00), P-value of test for trend =
0.008). CONCLUSIONS: No sufﬁcient evidence supporting that
the use of TCAs increases the risk of colorectal cancer. Our
results support the priori hypothesis that the use of SSRIs
decreases the risk of colorectal cancer.
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OBJECTIVE: To deﬁne a method of recognizing inﬂuence 
of comorbid conditions when studying outcomes of a speciﬁc
disease or therapy. Background: Patients are often suffering from
multiple disease states. When looking at resource utilization,
absenteeism, and other outcomes for a speciﬁc disease state or
therapy it is important to recognize the inﬂuence of other dis-
eases to the total costs and outcomes of the disease of interest.
METHODS: Several comorbidity indexes have been developed.
Well known and described are the Charlson Index with adapta-
tions, Index of Coexistent Disease, Cumulative Illness Rating
Scale, Chronic Disease Score and several other disease speciﬁc
indexes. The typical use of these indexes is predictive, a forecast
of mortality or costs based on the current history of a patient.
Many of these indexes require clinical information. The focus of
the current index is strictly toward administrative (claims) data-
bases. RESULTS: The methodology presented here is a nonlin-
ear transformation of the number of comorbid conditions, scaled
so that the probability of signiﬁcant comorbidity increases
monotonically with the number of conditions reported. This
AHRQ Comorbidity Index algorithms described by Elixhauser
are used to deﬁne a set of 31 comorbid conditions as deﬁned by
1111 ICD9 diagnoses. Sensitivity analysis of the number of
expected conditions resulted in a denominator of ten units.
CONCLUSIONS: The denominator to yield a percentage of
costs, outcomes, etc attributable to the comorbid conditions
divides the number of Elixhauser conditions, other than the
disease of interest. This index takes advantage of the longitudi-
nal nature of claims data to be inclusive of all disease states
within a patient and not just the current cause for treatment. It
provides an alternative approach to assign costs, absenteeism,
and other outcomes to a disease state that is a more accurate val-
uation of the outcomes without undue inﬂuence from other
comorbidities.
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OBJECTIVES: Inferring disease descriptions (e.g. asthma, mul-
tiple-sclerosis, etc) in a patient from his/her pharmacy proﬁle is
important in several sectors of health care such as insurance and
medical management. While the inference is relatively straight
forward in a few cases (e.g. diabetes in the presence of insulin),
very often the relationships are multifactorial. Manual, expert-
based processes for the task are unscalable and unmaintainable.
An automated, scalable and accurate method to infer disease
descriptions from a patient’s pharmacy proﬁle is the objective of
this study. METHODS: A large managed care database com-
prised of both medical and pharmacy claims was used for the
implementation. The pharmacy proﬁles were abstracted into
dummy variables based on First Data Bank drug classiﬁcation.
One dummy variable for each disease description based on
medical claims was created, and there were as many dummy vari-
ables as disease descriptions. For the current implementation,
Clinical Care Groups (a product of Ingenix) was chosen as the
disease description standard. To capture the multifactorial nature
of the relationships, logistic regression was used. The process of
creation of several such models was automated. The models were
evaluated based on standard metrics such as concordance rate,
false positives, sensitivity, etc. Performance of the models rela-
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tive to coding practices was also investigated. RESULTS: Over
100 models were implemented. Majority of the models were 
considered acceptable. Unacceptable models were produced for
conditions of low prevalence and ill-deﬁned conditions. Model
performance was also affected by coding practice (e.g. under-
coding for asthma, depression). CONCLUSIONS: A scalable
and automated method for inferring disease descriptions based
on pharmacy claims in a patient was successfully created. Appli-
cation-speciﬁc modiﬁcations to the method need some investi-
gation and are being pursued.
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OBJECTIVES: An implicit assumption in cost-effectiveness
analysis is that the value of the health beneﬁt (e.g., life year or
quality-adjusted life year gained) is directly proportional to the
gain, irrespective of baseline life expectancy. For example, a gain
of 6 months is valued the same, irrespective of whether the base-
line life expectancy is 40 years (e.g., for a healthy, middle-aged
adult) or 6 months (e.g., for a patient with metastatic cancer).
We examined the theoretical and empirical evidence regarding
the validity of this assumption. METHODS: We reviewed the
theoretical and empirical literature on the relationship between
the value of mortality reduction and life expectancy. We focused
our attention on outcome valuation using the willingness-to-pay
(WTP) and quality-adjusted life year (QALY) approaches.
RESULTS: Results of the review suggest that while research has
been conducted on the relationship between health gains and
baseline life expectancy due to age, the relationship between
health gains and baseline life expectancy due to health status
remains largely unexplored. Economic theory suggests that WTP
for risk reductions depends on baseline risk; however, the two
theoretical arguments (i.e., “dead anyway” and proportionality)
as to why this is so lead to opposite conclusions. QALYs are
assumed to be independent of baseline life expectancy, but this
assumption has been challenged by theorists who have proposed
the use of “age-weighted” measures. Empirical studies have
yielded mixed results. Stated and revealed values of life
expectancy gains are often associated with baseline life
expectancy, but the direction of the association is inconsistent.
CONCLUSIONS: The literature gives mixed support for the
assumption implicit in cost-effectiveness analysis that the value
of a survival gain is directly proportional to the gain and inde-
pendent of baseline life expectancy. Comparisons of cost per
QALY across populations with varying life expectancies should
recognize this limitation.
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OBJECTIVES: Discrete choice experiments (DCEs) are choice-
based methods used to estimate utilities. While DCEs are being
used increasingly in health economics, their application to esti-
mating utilities for health states and outcomes is more novel.
Visual analog scaling (VAS) is a well-established rating method
used widely in health care. Previous studies have shown that
DCE and VAS results are highly correlated. This study com-
pares state and attribute utilities for Barthel Index (BI) physical
disability states estimated by DCEs and the VAS method.
METHODS: A convenience sample of 152 subjects (≥ 45 years)
able to answer the 37-question survey was enrolled. Demo-
graphic characteristics, and physical disability and caregiving
histories were collected. The DCE consisted of 13 choice sets.
The VAS exercise used a rating thermometer (0 = worst imagin-
able health state, 20 = best imaginable health state) to rate 14
scenarios. The survey was administered in individual and small
group settings by trained researchers. Utilities for disability states
and attributes were analyzed using ordinary least squares and
probit regressions. Spearman correlations were calculated to
compare utilities and BI scores. RESULTS: Thirty-one percent of
the subjects were male, mean age was 61 years, 88% were Cau-
casian, 60% had more than a high school education, and 63%
were married. The strongest determinants of VAS utilities were
Feeding (p = .002), Continence (p = .003), Mobility (p < .001),
and Bathroom Use (p = .041). Feeding, Bathroom Use and Per-
sonal Care were the strongest determinants of DCE utilities (p <
.001). The relative contribution of Feeding was strongest in the
DCE model. Correlations between VAS and DCE utilities, and
BI scores were 96% and 91%, respectively. The correlation
between VAS and DCE utilities was 94%. CONCLUSIONS:
Although highly correlated, attribute contributions to DCE 
and VAS utilities differed. Subgroup analyses and exploration 
of design issues should help clarify the basis for the model 
differences.
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OBJECTIVES: To investigate characteristics associated with
being a non-trader and differences between trader and non-
trader groups. A limitation of utility elicitation using the Time
Trade-Off (TTO) method is that a substantial minority are inher-
ently non-traders, i.e. philosophically opposed to giving up any
amount of life in exchange for improved health. However, little
is known regarding characteristics associated with non-traders
or differences between traders and non-traders. METHODS: A
cross-sectional supervised self-administered survey was used to
assess the perception of health-related quality of life (HRQOL)
and utilities using the Time Trade-Off (TTO) method in the
general population of 3 groups: Caucasian Americans (n = 441),
African Americans (n = 344), Jamaicans (n = 41). Each person
was given one of three hypothetical health states. Logistic regres-
sion models were constructed and analyzed to investigate the
characteristics associated with being a non-trader. Independent
variables were age, gender, race/ethnicity, and importance of reli-
gion. We adjusted for current health. RESULTS: Of the 823 par-
ticipants, 17% were non-traders and 57% were female. Four
percent had not completed high school, 69% had a high school
degree and 27% had a college degree. In terms of importance of
religion, 3% reported that religion was not at all important, 6%
said religion was a little important, 23% said somewhat impor-
tant, and 68% said very important. Mean age of the population
